Streetbeat News

Revenues

AMZN

CMCSA

DIS

WBD

Warner Bros. Discovery Inc (NASDAQ:WBD) CEO David Zaslav is optimistic about retaining NBA rights against rivals like Comcast Corp's NBCUniversal and Amazon.com Inc's Prime Video. The competition could lead to higher fees for fewer NBA games for Warner and Disney. Zaslav believes in the appeal of Warner's sports lineup, including NCAA, NHL, and Nascar, despite potential financial challenges.

Portfolio Pulse from Shivani Kumaresan

May 09, 2024 | 5:56 pm

CRON

Cronos Group Inc. (NASDAQ:CRON) reported a 30% increase in net revenue for Q1 2024, reaching $25.3 million, primarily driven by sales in Canada and Israel. The company reduced its net loss to $2.48 million from $18.04 million in the same period last year. Gross profits rose by 53% to $4.48 million, and adjusted EBITDA losses decreased to $10.67 million. Cronos also reported $855 million in cash and equivalents, indicating strong financial positioning for future market expansion.

Portfolio Pulse from Nicolás Jose Rodriguez

May 09, 2024 | 5:18 pm

TOST

Over the last three months, 20 analysts have provided diverse opinions on Toast (NYSE:TOST), with recent updates showing a shift towards more positive ratings and higher price targets. The average 12-month price target has risen to $24.15, up 21.91% from the previous $19.81. Analysts from firms like Mizuho, Piper Sandler, and Goldman Sachs have adjusted their ratings and price targets, reflecting evolving market conditions and Toast's performance. Toast, a restaurant technology company, has shown notable revenue growth and processes a significant volume of transactions, despite its challenges in profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 5:01 pm

OSCR

Recent analyst evaluations of Oscar Health (NYSE:OSCR) show a mix of opinions, with 3 somewhat bullish and 1 indifferent rating in the last 30 days. The average 12-month price target for OSCR has been raised to $21.25, reflecting a 32.81% increase from the previous target of $16.00. Analysts from Wells Fargo, Goldman Sachs, and Raymond James have adjusted their ratings and price targets, indicating a positive outlook on the company's performance. Oscar Health's financials reveal a strong revenue growth rate of 45.8%, an impressive ROE of 19.32%, and an ROA of 4.42%, despite a net margin below industry averages and a smaller market capitalization.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 5:01 pm

HAIN

Hain Celestial Group (NASDAQ:HAIN) received mixed analyst ratings, with a shift towards a more cautious outlook. The average 12-month price target is now $9.83, down 19.43% from $12.20, reflecting lowered expectations. Analysts from firms like Maxim Group and Piper Sandler adjusted their ratings and price targets, indicating a response to Hain's market performance and financial challenges such as declining revenue and profitability metrics.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 5:00 pm

FXI

KBA

KWEB

MCHI

SPY

China's stock market has rebounded impressively after a sharp decline in January 2024, with key ETFs like KWEB, KBA, MCHI, and FXI outperforming major U.S. equity ETFs such as SPY. KraneShares CIO Brendan Ahern cites government support, changing global investor sentiments, policy reforms, economic recovery, and attractive valuations as drivers for this resurgence, suggesting a promising outlook for Chinese equities.

Portfolio Pulse from Surbhi Jain

May 09, 2024 | 4:50 pm

PRMW

Prime Water (PRMW) shares surged following the announcement of Q1 earnings surpassing expectations and an upward revision of its FY24 revenue forecast.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 4:27 pm

RUN

In the last three months, 9 analysts have provided diverse ratings on Sunrun (NASDAQ:RUN), with recent actions including both downgrades and upgrades. The average 12-month price target is now $20.78, down 3.89% from the previous $21.62. Sunrun faces challenges in market capitalization, revenue growth, profitability, and debt management, with significant declines in revenue and net margin. Analysts' ratings and price target adjustments reflect evolving market conditions and Sunrun's performance.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 4:01 pm

CART

Maplebear (NASDAQ:CART), also known as Instacart, has received diverse analyst ratings over the last three months, with a recent shift towards more bullish perspectives. The average 12-month price target for CART has been raised to $42.73, indicating a 19.96% increase from the previous target. Analysts from firms like Barclays, BMO Capital, and Morgan Stanley have raised their price targets, reflecting optimism about the company's market position and financial performance. Instacart's business model, focusing on online grocery delivery and pickup, along with its revenue growth and strong financial metrics such as net margin and ROE, supports the positive outlook.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 4:00 pm

LYFT

25 analysts have recently provided ratings for Lyft (NASDAQ:LYFT), showing a mix of bullish and bearish perspectives. The average 12-month price target for Lyft is now $18.16, up 17.77% from the previous $15.42, with individual analyst actions including rating upgrades and price target adjustments. Lyft's financials indicate a lower market capitalization compared to industry averages, a revenue growth of 4.22% as of December 31, 2023, and strong profitability metrics such as net margin and ROE despite lagging behind industry peers in revenue growth.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 4:00 pm